CDSCO Invites Comments on Pharma Brand Name Extensions' Legality
The CDSCO's notice regarding the scrutiny of brand name extensions used by pharma companies signals a shift towards regulatory oversight in the pharmaceutical sector. This inquiry may impact how brand identities are managed in compliance with drug regulations.





